2-Daiichi Sankyo-SAMSF-10-28-2021
Welcome to our virtual exhibit booth! |
|||
|
|
|||
About UsDaiichi Sankyo, Inc., the U.S. subsidiary of Daiichi Sankyo Co., Ltd., is headquartered in Basking Ridge, New Jersey, and is focused on the development of oncology and specialty medicines. Daiichi Sankyo, Inc. medicines approved in the U.S. include therapies for metastatic breast cancer, gastric cancer, tenosynovial giant cell tumor, hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, and IV iron therapy. |
|||
Links |
|||
Please click here for our virtual booth link. |
|||
|
|
|
||
Contact |
|||
| Heath St. Amant | |||
| Executive Oncology Territory Manager | |||
| hstamant@dsi.com | |||
| (228) 365-1820 | |||
